# Efficacy and Safety Study of SUNPG1622

> **NCT02980705** · PHASE2 · TERMINATED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 180 (actual)

## Conditions studied

- Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis

## Interventions

- **DRUG:** SUNPG1622 I dose
- **DRUG:** Placebo dose

## Key facts

- **NCT ID:** NCT02980705
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-06
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-09-03
- **Target enrollment:** 180 (ACTUAL)
- **Why stopped:** Study terminated-Sponsor's decision
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02980705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02980705, "Efficacy and Safety Study of SUNPG1622". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02980705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*